MiR-297 alleviates LPS-induced A549 cell and mice lung injury via targeting cyclin dependent kinase 8

Int Immunopharmacol. 2020 Mar:80:106197. doi: 10.1016/j.intimp.2020.106197. Epub 2020 Jan 13.

Abstract

In recent decades, microRNAs (miRNAs) have been reported to play an important role in the pathogenesis of acute lung injury/acute respiratory distress syndrome (ALI/ARDS). To explore the underlying mechanisms of miR-297 in ALI/ARDS, we investigated its role in lipopolysaccharide (LPS)-induced A549 cell and mice lung injury model. We found that the expression of miR-297 decreased in LPS-induced A549 cells or serum of ALI/ARDS mice. Moreover, LPS suppressed A549 cell viability, promoted apoptosis and increased the expressions of inflammatory and autophagy-related factors. Conversely, overexpression of miR-297 increased cell proliferation and reduced cell apoptosis, and alleviated inflammatory cytokines secretion and autophagy in the presence of LPS. Importantly, miR-297 directly inhibited transcription of cyclin dependent kinase 8 (CDK8) by binding to the 3'-untranslated region (3'-UTR) of CDK8 mRNA, and the expression of CDK8 was negatively regulated by miR-297. Silencing of CDK8 promoted the anti-inflammatory and anti-apoptotic effects of miR-297 in LPS-mediated A549 cells. The expressions of phosphorylated p65 (p-p65)/p65 and phosphorylated inhibitor kappa B-α (p-IκBα)/IκBα were dramatically decreased by miR-297 mimics and silencing of CDK8. In vivo, miR-297 alleviated LPS-induced inflammatory responses and lung injury in ALI/ARDS mice. In conclusion, our findings suggested that miR-297 affects nuclear factor-kappa B (NF-κB) pathway to alleviate LPS-induced A549 cell and mice lung injury via targeting CDK8 expression.

Keywords: ALI/ARDS; CDK8; LPS; miR-297.

MeSH terms

  • A549 Cells
  • Acute Lung Injury / blood
  • Acute Lung Injury / drug therapy
  • Acute Lung Injury / genetics*
  • Acute Lung Injury / immunology
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Apoptosis / immunology
  • Cyclin-Dependent Kinase 8 / genetics*
  • Disease Models, Animal
  • Humans
  • Lipopolysaccharides / immunology
  • Male
  • Mice
  • MicroRNAs / agonists
  • MicroRNAs / metabolism*
  • Phosphorylation / drug effects
  • Phosphorylation / genetics
  • Phosphorylation / immunology
  • Respiratory Distress Syndrome / drug therapy
  • Respiratory Distress Syndrome / genetics*
  • Respiratory Distress Syndrome / immunology
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Signal Transduction / immunology
  • Transcription Factor RelA / metabolism

Substances

  • Lipopolysaccharides
  • MIRN297 microRNA, human
  • MIRN297-1 microRNA, mouse
  • MIRN297a-2 microRNA, mouse
  • MicroRNAs
  • RELA protein, human
  • Transcription Factor RelA
  • CDK8 protein, human
  • Cdk8 protein, mouse
  • Cyclin-Dependent Kinase 8